Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter STEPI n study

Iversen, Lars; Eidsmo, Liv; Austad, Joar; A. de Rie, Menno; Osmančević, Amra; Skov, Lone; Talme, T.; Bachmann, Ingeborg; van de Kerkhof, Peter; Ståhle, Mona; Banerjee, Rudrani; B. Oliver, Joseph; E. R. Fasth, Andreas; Frueh, Jennifer

doi:10.1111/jdv.14979

Public

Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter STEPI n study

Published in Journal of the European Academy of Dermatology and Venereology • Apr 10, 2018

Authors:

Lars Iversen

Liv Eidsmo

Joar Austad

Abstract

BACKGROUND: To date, biological treatments have been assessed in subjects with a long-term history of psoriasis and previous failures to systemic and topical therapies. In rheumatoid arthritis and other immune-mediated inflammatory diseases, early intensive systemic treatment prolongs treatment-free...

Subject

Medicine

Secukinumab

Psoriasis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!